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Abstract
Urological complications after kidney transplantation are mostly related to the ureteroneocystostomy, often requiring
interventions with additional costs, morbidity and mortality. Our aim was to assess risk factors for urological complications
in deceased donor kidney transplantation. Between January 2000 and December 2011, 566 kidney transplantations were
performed with deceased donor kidneys. Recipients were divided in a group with, and a group without urological
complications, defined as the need for a percutaneous nephrostomy catheter or surgical revision of the ureteroneocys-
tostomy. Univariate and multivariate analyses were performed. Univariate analysis showed increased number of male
donors (p = 0.041), male recipients (p = 0.002), pre-emptively transplanted recipients (p = 0.007), and arterial reconstructions
(p = 0.004) in the group with urological complications. Less urological complications occurred in recipients on hemodialysis
(p = 0.005). More overall surgical interventions (p,0.001), surgical site infections (p = 0.042), urinary tract infections (p,
0.001) and lymphoceles (p,0.001) occurred in the group with urological complications. Multivariate analysis showed that
male recipients (p = 0.010) and arterial reconstructions (p = 0.019) were independent risk factors. No difference was found
between both groups in patient or graft survival. In conclusion, recipient male gender and arterial reconstruction are
independent risk factors for urological complications after deceased donor kidney transplantation. Nevertheless, graft and
recipient survival is not different between both groups.
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Introduction
Urological complications after kidney transplantation are
reported to occur between 2.5% and 30% of all recipients
[1,5,17,21,24]. Major urological complications, for example
leakage and stenosis, are often related to the ureteroneocystostomy
[2,10,13,19,22]. In most cases these complications require
placement of a percutaneous nephrostomy (PCN). Sometimes,
even a surgical revision is required, leading to additional morbidity
and costs [4,5,22].
Risk factors that contribute to the prevalence of urological
complications need to be determined. So far, many factors have
been described in literature, including several donor and recipient
characteristics [15,21]. Furthermore, problems encountered dur-
ing graft recovery, prolonged ischemia times, type of ureteroneo-
cystostomy, presence of accessory arteries or stent placement
might be of influence on the incidence of urological complications
[2,4,20,21].
Due to the increasing number of patients with end-stage kidney
disease and a continuing shortage of donors, the demand for
kidney grafts led to extension of donor criteria by the Dutch
Transplant Foundation. Alongside the Donation after Brain Death
(DBD) donors, Donation after Circulatory Death (DCD) (category
III) donors have been deemed eligible for transplantation [9–12].
A higher percentage of urological complications after deceased
kidney donation has been reported, when compared to live donor
kidney transplantation [4,22]. We aimed to assess the incidence of
urological complications after kidney transplantation with grafts
from DBD and DCD donors and identify independent factors
associated with the development of these complications, in a
multivariate analysis.
Patients and Methods
The Erasmus MC, University Medical Center internal review
board issued a formal written waiver for the need of ethics
approval and the need for written informed consent.
Between January 2000 and December 2011, all kidney
transplantations performed with grafts from DBD and DCD
(category III) donors at the Erasmus University Medical Center
Rotterdam, were reviewed retrospectively. A total of 566 recipients
were identified. The surgical reports and electronic patient system
were screened for donor and recipient characteristics, and
urological complications. Recipients were divided in two groups,
one group with and one group without urological complications
within 3 months’ time after transplantation. A urological
complication was defined as any event leading to the placement
of a PCN or surgical revision of the ureteroneocystostomy during
follow-up. We argued that a PCN placement is the best possible
parameter to identify those patients who had an adverse urological
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outcome. An increasing serum creatinine level combined with
hydronephrosis on ultrasonography was reason for a PCN
placement. Monitoring of the PCN position and imaging of the
ureter is performed by an antegrade pyelography (APG). If leakage
of the ureteroneocystostomy is diagnosed with an APG, both PCN
and urinary bladder catheter are placed until the leakage stops. In
case the leakage is diagnosed shortly after transplantation
immediate surgical reconstruction is performed. If a total
obstruction of the ureter is diagnosed with an APG, surgical
intervention is inevitable. If the APG shows a stenosed ureter but
contrast reaches the bladder radiological dilation of the ureter is
performed. Afterwards a percutaneous nephrocystostomy catheter
(PCNC) is placed for 2 weeks. If the stenosis persists a surgical
ureter reconstruction is indicated and will be performed by a
transplant surgeon, together with an urologist.
Overall Complications
Tacrolimus toxicity (.15 mg/l), suspected acute tubulus necro-
sis (ATN), treatment for rejection (methylprednisolone and/or
ATG), lymphoceles, surgical site infections and urinary tract
infections were scored during the first 3 months after transplan-
tation. Besides ureteral revisions, all other re-interventions were
documented: re-interventions because of re-bleeding, lymphocele
drainage, transplantectomy and re-exploration because of vascular
complications. Graft failure was defined as primary non-function
or loss of function requiring dialysis. All recipients had a follow-up
of at least one year in our center.
Surgical Technique
All transplantations were performed by a transplant surgeon or
vascular surgeon and transplants were engrafted extraperitoneally
in the iliac fossa. In presence of multiple renal arteries (in majority
of cases two arteries) a reconstruction was performed on the
bench. Dependent on the length of the artery an end-to-side or an
side-to-side anastomosis was created. Urinary continuity was
established by either an intravesical [18] (Politano-Leadbetter) or
extravesical [7] (Lich-Gregoir) ureteroneocystostomy. Intravesical
anastomoses were created by performing a cystotomy on the
anterior side to visualize the interior of the bladder and expose the
trigone. A second (smaller) cystostomy was performed to create a
new ureteric orifice. The ureter of the transplanted kidney as
tunneled submucosally for approximately 2 centimeters. The distal
end was trimmed, spatulated anteriorly at an optimal length to
ensure a tension-free anastomosis and sutured to the bladder
mucosa with 5–6 interrupted absorbable stitches. The cystotomy
was then closed with a running suture. Extravesical anastomoses
were created by performing a 1–2 centimeter cystotomy on the
anterolateral surface of the bladder dome to expose the mucosa of
the bladder wall. A small incision was made in the mucosa. The
transplant ureter was trimmed and spatulated posteriorly. The
mucosa of the bladder was sutured to the ureteral end with a
running absorbable suture. The detrusor muscle was closed over
the anastomosis using one or two interrupted absorbable sutures to
create a submucosal tunnel with an anti-reflux mechanism.
Placement of a stent depended on pre-transplant urinary
production, so that urinary production of the transplanted kidney
can be determined. Stents were externalized suprapubicly with the
tip positioned in the pelvis of the graft and removed after 10 days.
Postoperative Medical Care
Postoperatively, immunosuppressive therapy consisted of pred-
nisolone (50 mg a day), tacrolimus (dose was titrated based on
serum value) and mycophenolate mofetil (1000 mg twice a day).
Basiliximab was used as induction therapy. Prednisolone was
tapered and discontinued 4 months after transplantation. A
prophylactic dose of 480 mg cotrimoxazole per day was given to
prevent urinary tract infections. Cefazoline was given periopera-
tively. Standard dose of 12.000 U heparin daily was given during
the first 5 post-operative day. Valganciclovir treatment was given
to patients at risk for CMV infection or reactivation. Initial
episodes of acute rejection were treated with methylprednisolone,
1000 mg a day for 3 days, ATG was given on indication.
Statistical Analyses
Statistical analysis was performed using IBM SPSS version 20.0
(IBM Corp., Armonk, NY, USA). Variables studied are presented
in Table 1 and Table 2. Categorical variables are presented as
number (percentage) and were compared using the Chi-square
test. Continuous variables are presented as mean with standard
deviation (SD) and were compared using an independent sample
T-test. We calculated odds ratios (OR) with 95% confidence
intervals (CI), using a univariate and multivariate generalized
linear model to identify independent risk factors for urological
complications. All variables with a p-value ,0.10 in the univariate
analysis were included in the multivariate analysis. A p-value of ,
0.05 in our multivariate model was considered statistically
significant. Graft and patient survival were analyzed using a
Kaplan-Meier curve for survival distribution and compared using
a log-rank test.
Ethics
The manuscript is conducted in accordance to the principles
expressed in the Declaration of Helsinki. Approval of our local
ethics committee was not required for this study.
Results
Baseline Characteristics
Between January 2000 and December 2011, 566 kidney
transplantations were performed with grafts from both DBD and
DCD donors. An overview of the baseline characteristics is shown
in Table 1. Urological complications were significantly more
frequent in male donors, male recipients, pre-emptive transplan-
tations and arterial reconstructions. Significantly less recipients on
hemodialysis developed a urological complication. The number of
kidney grafts from DBD and DCD donors was equally distributed
in the group with and without urological complications.
Urological Complications
Of the total 566 recipients, 117 received a PCN. In 15 recipients
a PCN was placed because of leakage and in 102 because of
hydronephrosis on ultrasonography. An endoscopic dilatation of
the ureter was performed in 4 recipients, in 3 patients successfully
and in 1 recipient an additional surgical revision was required
afterwards. A surgical ureteral revision was required in 31
recipients who previously received a PCN and in one recipient a
surgical ureteral revision was required without a prior PCN
placement based on leakage of the ureter shortly after transplan-
tation. Choice of re-implantation was in 30 cases a new
ureterovesicostomy, in one patient a pyelovesicostmy and in one
a ureter-ureterostomy. Mean graft survival of the group with a
surgical ureter reconstruction was 5.57 years (inter quartile range
of 2.14–9.27). In 83 recipients, the PCN could be removed without
additional intervention.
Overall Complications
Comparisons of the overall complications according to absence
or presence of urological complications are presented in Table 2.
Urological Complications in Kidney Transplantation
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There were significantly more overall surgical interventions,
surgical site infections, urinary tract infections and lymphoceles
in the group of recipients with urological complications. Primary
non-function prevailed significantly less frequently in recipients
with urological complications.
Multivariate Analysis
All odds ratios regarding urological complications using
univariate and multivariate analysis were presented in Table 3.
Five factors (donor gender, recipient gender, pre-emptive trans-
plantation, hemodialysis, arterial reconstruction) implemented in
our univariate analysis showed a significant influence on the
presence of urological complications and were therefore analyzed
in a multivariate model. Recipient gender and arterial reconstruc-
tion were identified as independent risk factors in our multivariate
analysis.
Donor Type and Urological Complications
In total 118 (20.8%) recipients developed a urological compli-
cation and 5.7% of all recipients (32 out of 566) underwent a
surgical ureteral revision. Of all recipients who developed a
urological complication, 73 had a DBD donor graft and 45 a
DCD. Table 4 shows that DBD and DCD transplantations were
not different regarding prevalence of urological complications.
However, there were significantly more surgical site infections in
the DCD group.








Male gender (%) 293 (51.8%) 222 (49.6%) 71 (60.2%) 0.041
Age (mean) (SD) 50.48 (14.45) 50.35 (14.28) 51.01 (15.12) 0.661
DBD (%) 352 (62.0%) 279 (62.3%) 73 (61.9%) 0.934
Recipients
Male gender (%) 351 (62.0%) 263 (58.7%) 88 (74.6%) 0.002
Age (mean) (SD) 52.96 (13.95) 52.70 (13.77) 53.98 (14.65) 0.376
Multiple transplantations (%) 137 (24.2%) 108 (24.1%) 29 (24.6%) 0.916
Diabetes Mellitus (%) 130 (23.0%) 105 (23.4%) 25 (21.2%) 0.651
Pre-emptive transplantation (%) 20 (3.5%) 11 (2.5%) 9 (7.6%) 0.007
Hemodialysis (%) 383 (67.7%) 316 (70.5%) 67 (56.8%) 0.005
BMI (SD) 25.75 (5.03) (n = 516) 25.87 (5.11) (n = 405) 25.33 (4.75) (n = 111) 0.322
Grafts
Warm ischemic time (mean in minutes) (SD) 38.67 (18.72) 38.76 (19.42) 38.36 (15.89) 0.837
Cold ischemic time (mean in minutes) (SD) 1083.42 (350.59) 1083.57 (349.37) 1082.84 (356.73) 0.984
Arterial reconstruction (%) 70 (12.4%) 46 (10.3%) 24 (20.3%) 0.004
Extravesical ureteroneocystostomy (%) 124 (21.9%) 98 (22.1%) 26 (22.4%) 0.946
Stent placement (%) 273 (48.2%) 213 (47.7%) 60 (51.3%) 0.484
*p-value is provided between the group without urological complications and the group with urological complications.
SD: Standard Deviation; DBD: Donation after Brain Death; BMI: Body Mass Index.
doi:10.1371/journal.pone.0091211.t001







Overall surgical intervention (%) 132 (23.3%) 85 (19.0%) 47 (39.8%) ,0.001
ATN (%) 240 (42.4%) 187 (41.7%) 53 (44.9%) 0.535
Tacrolimus toxicity (.15 mg/l) (%) 63 (11.1%) 47 (10.5%) 16 (13.6%) 0.346
Surgical site infection (%) 50 (8.8%) 34 (7.6%) 16 (13.6%) 0.042
Urinary tract infection (%) 130 (23.0%) 84 (18.8%) 46 (39.0%) ,0.001
Lymphocele (%) 17 (3.0%) 3 (0.7%) 14 (11.9%) ,0.001
Rejection treatment (%) 71 (12.5%) 54 (12.0%) 17 (14.4%) 0.492
Primary non-function (%) 51 (9.0%) 46 (10.3%) 5 (4.2%) 0.042
*p-value is provided between the group without urological complications and the group with urological complications.
PCN: Percutaneous Nephrostomy; ATN: Acute Tubulus Necrosis.
doi:10.1371/journal.pone.0091211.t002
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Follow-up
Mean graft survival time was 4.02 years with a standard
deviation of 3.47. Minimum graft survival was 0 day due to
primary non function and maximum was 12.1 years. Mean patient
survival was 5.13 years. Death censored graft survival regarding
urological complications was presented by a Kaplan-Meier curve
(Figure 1). No significant difference occurred in graft survival
between the group with or without urological complications
(p = 0.707).
Discussion
In our study, 20.8% of all recipients of a kidney graft from a
deceased donor had a urological complication as defined by PCN
placement or surgical ureteral revision. As PCN placement is
considered as a minimally invasive event in our center, the
threshold to use a PCN is low, either for therapy, or for diagnosis.
Eventually, only 32 recipients (5.7%) underwent a surgical ureteral
revision for leakage or stenosis and graft survival was not worse in
the population with urological complications.
It has been suggested that urological complications are caused
by an insufficient blood supply to the ureter. Excessive dissection
of the site known as ‘golden triangle’ (the site confined by ureter,
kidney and renal artery) should therefore be avoided during graft
recovery. Damage of this triangle might lead to necrosis of the
distal ureter in 70% of the cases [4,13,17].
Potential risk factors for urological complications including age,
prolonged cold ischemia and recipient Diabetes Mellitus were
reported not to play an important role in the occurrence of
urological complications [4,21]. These findings are supported by
our data (Table 1). In our study more urological complications
occurred in male donors, male recipients and pre-emptive
transplantations. The reason why male recipients may develop
more urological complications is not exactly clear. An anatomical
cause due to the presence of the funiculus that crosses the ureter
Table 3. Results of the multivariate analysis regarding urological complications.
Variable Univariate OR (95% CI) p-value* Multivariate OR (95% CI) p-value*
Donors
Male gender 1.57 (1.02–2.33) 0.041 1.46 (0.96–2.24) 0.080
Recipients
Male gender 2.06 (1.32–3.29) 0.002 1.84 (1.15–2.93) 0.010
Pre-emptive transplantation 3.28 (1.29–8.12) 0.007 2.20 (0.82–5.81) 0.111
Hemodialysis 0.55 (0.36–0.83) 0.005 0.66 (0.42–1.04) 0.073
Grafts
Arterial reconstruction 2.23 (1.28–3.81) 0.004 1.96 (1.10–3.40) 0.019
*p-value is provided between the group without urological complications and the group with urological complications.
OR: Odds Ratio; CI: Confidence Interval.
doi:10.1371/journal.pone.0091211.t003
Table 4. Characteristics and complications of the recipients with urological complications.
Total (n = 118) DBD (n=73) DCD (n=45) p-value*
Ureteral reconstruction (%) 32 (27.1%) 24 (32.9%) 8 (17.8%) 0.130
Male gender recipient (%) 88 (74.6%) 54 (74.0%) 34 (75.6%) 0.848
Male gender donor (%) 71 (60.2%) 41 (56.2%) 30 (66.7%) 0.258
Arterial reconstruction (%) 24 (20.3%) 16 (21.9%) 8 (17.8%) 0.587
Urinary tract infection (%) 46 (39.0%) 28 (38.4%) 18 (40.0%) 0.859
Surgical site infection (%) 16 (13.6%) 6 (8.2%) 10 (22.2%) 0.031
Lymphocele (%) 14 (11.9%) 9 (12.3%) 5 (11.1%) 0.843
*p-value is provided between the DBD and DCD group.
DBD: Donation after Brain Death; DCD: Donation after Circulatory Death;
PCN: Percutaneous Nephrostomy.
doi:10.1371/journal.pone.0091211.t004
Figure 1. Kaplan-Meier survival, the black line corresponds to
the group with urological complications and the grey line
corresponds to the group without urological complications.
This curve is censored for death. No significant difference occurred
between both groups (p = 0.707).
doi:10.1371/journal.pone.0091211.g001
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might be an explanation, considering the ligamentum rotundum is
ligated in females during the implantation. Furthermore, arterial
reconstruction of the donor graft was highly associated with the
prevalence of urological complications (Table 1), which is
confirmed in the literature [3,6,14]. Relative ischemia of the
ureter by an insufficient arterial blood supply is suggested to be the
cause for leakage and stenosis. Malperfusion of accessory arteries
may result from a small anastomosis with flow-limitation, greater
turbulence or more vulnerability for traction injury.
There is growing evidence on the superiority of the extravesical
ureteroneocystostomy when compared with the intravesical
technique, with or without additional routine stent placement
[1,2,8,16,20,23]. In our population, the type of ureteroneocystos-
tomy was depended on surgeons’ preference and stent placement
on residual urinary production. Both, type of ureteroneocystosto-
my and the presence of a stent could not be defined as a risk factor
in our analysis (Table 1). However, there were significantly more
surgical site infections, urinary tract infections, lymphoceles and
surgical re-explorations because of hemorrhage, transplantec-
tomies or vascular complications (Table 2), in the group with
urological complications.
Although the mean graft survival of DCD donors is suspected to
be shorter than that of DBD donors, there are no studies on the
occurrence of urological complications in those groups. Therefore,
the finding that grafts from a DBD donor were not superior to
DCD donor grafts with respect to urological complications
(Table 4) is an important finding. In addition, our Kaplan Meier
survival analysis (Figure 1) demonstrates no difference in long term
graft survival between the populations with and without urological
complications which is supported by other studies [1,4,22]. It
should however be kept in mind that the population with
urological complications is a selection with a functioning graft.
Another important finding in our study was the fact that
primary non-function of the graft or graft loss within 3 months was
significantly lower in the group without urological complications
(Table 2). This probably is a bias since urological complications
like leakage and hydronephrosis by a stenosis at the ureteroneo-
cystostomy junction site cannot be detected in a non-functioning
graft. Furthermore, recipients transplanted pre-emptively, had a
significantly higher risk to develop urological complications. There
is no clear explanation for this finding. However, this subgroup
consists of only 20 recipients, which might have biased the
statistical outcome. One other limitation of our study is the fact
that some potential risk factors, such as donor BMI, ureteral
vascularization or length of the ureter could not be documented
prospectively. Despite the retrospective character of our study and
its disadvantages, we describe the most detailed group regarding
urological complications of kidney graft recipients from a deceased
donor so far as known from the literature.
Based on our study of kidney transplantations from a deceased
donor, we conclude that recipient’s gender and arterial recon-
struction are independent risk factors to develop a urological
complication. However, donor type (DBD and DCD), primary
non-function, type of anastomosis, and the presence of multiple
transplantations could not be defined as risk factor in our
univariate and multivariate analyses. This means that donor type
and surgical anastomosis technique are less important factors for
the urological outcome, which is in contrast to what one might
argue.
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